This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xopr [2020/06/23 12:25] jfpothier |
bacteria:t3e:xopr [2020/07/09 12:11] (current) rkoebnik [XopR] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== XopR ====== | ====== XopR ====== | ||
- | Author: Fernando Tavares\\ | + | Author: |
- | Reviewer: Amandine Cunty\\ | + | Reviewer: |
Expert reviewer: FIXME | Expert reviewer: FIXME | ||
Class: XopR\\ | Class: XopR\\ | ||
Family: XopR\\ | Family: XopR\\ | ||
- | Prototype: | + | Prototype: |
- | RefSeq ID: XopR [[https:// | + | RefSeq ID: XopR [[https:// |
+ | 3D structure: Unknown | ||
===== Biological function ===== | ===== Biological function ===== | ||
Line 21: | Line 22: | ||
Functional studies using // | Functional studies using // | ||
+ | |||
+ | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//) were significantly reduced in the // | ||
=== Phenotypes === | === Phenotypes === | ||
- | In the last few years a comprehensive body of experimental evidence has been gathered supporting a multiple action of XopR in hampering host plant defenses, namely by fostering bacterial growth //in planta//, and suppressing pathogen-associated molecular patterns (PAMP) triggered host plant immunity (PTI) (Akimoto-Tomiyama //et al//., 2012; Wang //et al//., 2016; Medina //et al//., 2018; Verma //et al//., 2018; Verma //et al//., 2019). In fact, early studies suggested that XopR suppress PAMP-triggered stomatal closure in transgenic // | + | In the last few years a comprehensive body of experimental evidence has been gathered supporting a multiple action of XopR in hampering host plant defenses, namely by fostering bacterial growth //in planta//, and suppressing pathogen-associated molecular patterns (PAMP) triggered host plant immunity (PTI) (Akimoto-Tomiyama //et al//., 2012; Wang //et al//., 2016; Medina //et al//., 2018; Verma //et al//., 2018; Verma //et al//., 2019). In fact, early studies suggested that XopR suppress PAMP-triggered stomatal closure in transgenic // |
=== Localization === | === Localization === | ||
Line 45: | Line 48: | ||
===== References ===== | ===== References ===== | ||
- | Akimoto-Tomiyama C //et al//. (2012). XopR, a Type III Effector Secreted | + | Akimoto-Tomiyama C, Furutani A, Tsuge S, Washington EJ, Nishizawa Y, Minami E, Ochiai H (2012). XopR, a type III effector secreted |
+ | |||
+ | Furutani A, Nakayama T, Ochiai H, Kaku H, Kubo Y, Tsuge S (2006). Identification of novel HrpXo regulons preceded by two // | ||
+ | |||
+ | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | ||
- | Furutani A //et al//. (2006). Identification of novel HrpXo regulons preceded by two cis-acting elements, a plant-inducible promoter box and a −10 box-like sequence, from the genome database | + | Kametani-Ikawa Y, Tsuge S, Furutani A, Ochiai H (2011). An H-NS-like protein involved in the negative regulation |
- | Furutani A //et al//. (2009). Identification of Novel Type III Secretion Effectors in // | + | Liu Y, Long J, Shen D, Song C (2016). // |
- | Kametani-Ikawa Y //et al//. (2011). An H-NS-like protein involved in the negative regulation | + | Medina CA, Reyes PA, Trujillo CA, Gonzalez JL, Bejarano DA, Montenegro NA, Jacobs JM, Joe A, Restrepo S, Alfano JR, Bernal A (2018). The role of type III effectors from // |
- | Medina CA //et al//. (2018). The role of type III effectors from // | + | Verma G, Sharma M, Mondal KK (2018). XopR TTSS-effector regulates |
- | Verma G, Sharma M, Mondal KK (2018). XopR TTSS-effector | + | Verma G, Mondal KK, Kulshreshtha A, Sharma M (2019). XopR T3SS-effector of // |
- | Verma G //et al//. (2019). XopR T3SS-effector of // | + | Wang S, Sun J, Fan F, Tan Z, Zou Y, Lu D (2016). A // |
- | Wang S //et al//. (2016). A // | + | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // |
- | White FF //et al//. (2009). The type III effectors | + | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL |